Rehabilitation of falls in patients with iatrogenic chemotherapy–induced neuropathy
- 33 Downloads
We have read with particular interest the recent article titled “Assessing risk factors of falls in cancer patients with chemotherapy-induced peripheral neurotoxicity” by Argyriou and colleagues . This large and insightful study aims to identify factors related to risk of falls in patients affected by chemotherapy-induced peripheral neuropathy (CIPN), suggesting the combination of the Total Neuropathy Score and a precise clinical assessment could represent a cost-effective and easy predictor .
This work is particularly important for several motives. The paper states how falls in patients affected by CIPN present copious individual and social costs. In fact, this condition affects directly on the quality of life (QoL) of patients and their relatives and heavily impacts on the healthcare system . For these reasons, identification of factors predisposing to falls, to prevent them, is a worldwide priority in elderly [2, 3], musculoskeletal diseases ,...
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Argyriou AA, Bruna J, Anastopoulou GG, Velasco R, Litsardopoulos P, Kalofonos HP (2019) Assessing risk factors of falls in cancer patients with chemotherapy-induced peripheral neurotoxicity. Support Care Cancer. https://doi.org/10.1007/s00520-019-05023-5
- 5.Cattaneo D, Gervasoni E, Pupillo E et al (2019) Mobility disorders in stroke, Parkinson’s disease and multiple sclerosis. Am J Phys Med Rehabil. https://doi.org/10.1097/PHM.0000000000001272
- 7.McCrary JM, Goldstein D, Trinh T, Timmins HC, Li T, Menant J, Friedlander M, Lewis CR, Hertzberg M, O'Neill S, King T, Bosco A, Harrison M, Park SB (2019) Balance deficits and functional disability in cancer survivors exposed to neurotoxic cancer treatments. J Natl Compr Cancer Netw 17:949–955. https://doi.org/10.6004/jnccn.2019.7290 CrossRefGoogle Scholar